Tianeptine, initially created as a therapeutic compound in Europe , has generated considerable debate internationally. Unlike typical antidepressants which act by boosting serotonin levels, tianeptine suggests to improve serotonin reuptake and affects brain chemistry, resulting in atypical responses. Its accessibility through unregulated channels ,